.svg){kind=small}
Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Emerald Health Therapeutics has shown fluctuating performance in the beverage category in Ontario. Over the months from August to November 2025, the brand experienced a downward trend in sales, starting at $41,986 in August and dropping to $15,526 by November. This decline is reflected in their ranking, which saw a slight drop from 20th in August to 24th in November. The brand's presence in the top 30 indicates a maintained relevance, but the downward movement suggests challenges in maintaining competitive positioning or possibly external market pressures impacting sales.
Interestingly, while Emerald Health Therapeutics managed to stay within the top 30 in Ontario's beverage category, the absence of ranking data for other states or provinces suggests that they did not secure a top 30 position elsewhere. This could imply a more localized market focus or potential growth opportunities in unexplored regions. The brand's fluctuating rankings in Ontario highlight the competitive nature of the cannabis beverage market and the need for strategic adjustments to regain or improve its standing. Further details on their performance in other provinces or categories might provide additional insights into their overall market strategy and execution.
Competitive Landscape
In the Ontario beverage category, Emerald Health Therapeutics has experienced a fluctuating position in the rankings, dropping from 20th in August 2025 to 24th by November 2025. This decline in rank is paralleled by a decrease in sales, suggesting a challenging competitive landscape. Notably, Embody has shown a positive trajectory, moving up from 27th in August to 22nd in November, indicating a strengthening market presence. Meanwhile, Summit (Canada) has climbed from being unranked in August to 23rd in November, showcasing a significant upward trend. Conversely, Dulces experienced a decline, moving from 19th in September to 26th in November, which could provide an opportunity for Emerald Health Therapeutics to reclaim market share if they can capitalize on Dulces' downturn. The competitive dynamics in this category highlight the need for Emerald Health Therapeutics to innovate and adapt to regain its footing in the market.
Notable Products
In November 2025, the top-performing product for Emerald Health Therapeutics was the Cranberry Citrus Live Rosin Beverage (10mg THC, 222ml), maintaining its first-place rank for four consecutive months despite a decline in sales to 998 units. Lime Mint Beverage (10mg THC, 222ml) rose to second place, improving from its fourth-place rank in October. The Agave Lime Sea Salt Live Rosin Beverage (10mg THC, 222ml) dropped to third place, having been second in October. Meanwhile, Ginger Lime Live Rosin Beverage (10mg THC, 222ml) fell to fourth place, continuing its downward trend from earlier months. Notably, SYNC 25 CBD Oil (40ml) did not have sufficient sales data for ranking in November.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
